Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
07/03/2025 21:36
March 7 (Reuters) - Avenue Therapeutics Inc ATXI.O: AVENUE THERAPEUTICS INC - ANNJI INTENDS TO TERMINATE LICENSE AGREEMENT WITH CO Further company coverage: ATXI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary